Difference between revisions of "Valganciclovir (Valcyte)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
m (→Also known as) |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
Antiviral with particular activity against cytomegalovirus (CMV). | Antiviral with particular activity against cytomegalovirus (CMV). | ||
+ | |||
+ | ==Also known as== | ||
+ | *'''Brand names:''' Cytomega, VagaCyte, Valcyclovir, Valcyte, Valgan, Valixa, Valnov, Virolfi, V-Gavir | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
− | [[Category: | + | [[Category:Viral DNA synthesis inhibitors]] |
− | + | [[Category:FDA approved in 2001]] | |
− | [[Category: |
Latest revision as of 18:20, 27 February 2020
Antiviral with particular activity against cytomegalovirus (CMV).
Also known as
- Brand names: Cytomega, VagaCyte, Valcyclovir, Valcyte, Valgan, Valixa, Valnov, Virolfi, V-Gavir